New hope for debilitating dizziness? study tests migraine drugs
NCT ID NCT07203248
Summary
This study aims to see how well a newer class of migraine drugs (CGRP-targeted medications) works for treating vestibular migraine, a condition that causes severe dizziness and vertigo. It will follow 2,000 Chinese patients in a real-world setting to measure if these drugs can reduce the severity of acute attacks and decrease how often they happen. The goal is to gather better evidence for managing this challenging condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIZZINESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.